By Professor Glenda Halliday

Journal articles

Forrest SL; Halliday GM; Shepherd CE; Kwok JB; Hallupp M; Kril JJ, 2020, 'Are mutations in MAPT associated with GGT type III?', Neuropathology and Applied Neurobiology, 46, pp. 406 - 409, http://dx.doi.org/10.1111/nan.12583

van der Lee SJ; Conway OJ; Jansen I; Carrasquillo MM; Kleineidam L; van den Akker E; Hernández I; van Eijk KR; Stringa N; Chen JA; Zettergren A; Andlauer TFM; Diez-Fairen M; Simon-Sanchez J; Lleó A; Zetterberg H; Nygaard M; Blauwendraat C; Savage JE; Mengel-From J; Moreno-Grau S; Wagner M; Fortea J; Keogh MJ; Blennow K; Skoog I; Friese MA; Pletnikova O; Zulaica M; Lage C; de Rojas I; Riedel-Heller S; Illán-Gala I; Wei W; Jeune B; Orellana A; Then Bergh F; Wang X; Hulsman M; Beker N; Tesi N; Morris CM; Indakoetxea B; Collij LE; Scherer M; Morenas-Rodríguez E; Ironside JW; van Berckel BNM; Alcolea D; Wiendl H; Strickland SL; Pastor P; Rodríguez Rodríguez E; Mead S; Synofzik M; van Swieten JC; Leber I; Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Blesa R; Landqvist Waldö M; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A, 2020, 'Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)', Acta Neuropathologica, 139, pp. 959 - 962, http://dx.doi.org/10.1007/s00401-019-02107-8

Shepherd CE; Affleck AJ; Bahar AY; Carew-Jones F; Halliday GM, 2020, 'Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Aβ and tau pathology', Neurobiology of Aging, 89, pp. 129 - 131, http://dx.doi.org/10.1016/j.neurobiolaging.2019.10.025

Hughes LP; Halliday GM; Dzamko N, 2020, 'Flow Cytometry Measurement of Glucocerebrosidase Activity in Human Monocytes', Bio-protocol, 10, http://dx.doi.org/10.21769/BioProtoc.3572

Ling H; Gelpi E; Davey K; Jaunmuktane Z; Mok KY; Jabbari E; Simone R; R’Bibo L; Brandner S; Ellis MJ; Attems J; Mann D; Halliday GM; Al-Sarraj S; Hedreen J; Ironside JW; Kovacs GG; Kovari E; Love S; Vonsattel JPG; Allinson KSJ; Hansen D; Bradshaw T; Setó-Salvia N; Wray S; de Silva R; Morris HR; Warner TT; Hardy J; Holton JL; Revesz T, 2020, 'Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates', Acta Neuropathologica, 139, pp. 717 - 734, http://dx.doi.org/10.1007/s00401-019-02119-4

Piras IS; Bleul C; Talboom JS; De Both MD; Schrauwen I; Halliday G; Myers AJ; Serrano GE; Beach TG; Huentelman MJ, 2020, 'ESHRD: Deconvolution of brain homogenate rna expression data to identify novel cell-type-specific alterations in Alzheimer's disease', Aging, 12, pp. 4124 - 4162, http://dx.doi.org/10.18632/aging.102840

Amadoru S; Doré V; McLean CA; Hinton F; Shepherd CE; Halliday GM; Leyton CE; Yates PA; Hodges JR; Masters CL; Villemagne VL; Rowe CC, 2020, 'Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease', Alzheimer's Research and Therapy, 12, http://dx.doi.org/10.1186/s13195-020-00587-5

Dobson-Stone C; Hallupp M; Shahheydari H; Ragagnin AMG; Chatterton Z; Carew-Jones F; Shepherd CE; Stefen H; Paric E; Fath T; Thompson EM; Blumbergs P; Short CL; Field CD; Panegyres PK; Hecker J; Nicholson G; Shaw AD; Fullerton JM; Luty AA; Schofield PR; Brooks WS; Rajan N; Bennett MF; Bahlo M; Shankaracharya ; Landers JE; Piguet O; Hodges JR; Halliday GM; Topp SD; Smith BN; Shaw CE; McCann E; Fifita JA; Williams KL; Atkin JD; Blair IP; Kwok JB, 2020, 'CYLD is a causative gene for frontotemporal dementia - Amyotrophic lateral sclerosis', Brain, 143, pp. 783 - 799, http://dx.doi.org/10.1093/brain/awaa039

Tan RH; Halliday GM, 2020, 'Author response: The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability', Neurology, 94, pp. 283, http://dx.doi.org/10.1212/WNL.0000000000008921

Moore KM; Nicholas J; Grossman M; McMillan CT; Irwin DJ; Massimo L; Van Deerlin VM; Warren JD; Fox NC; Rossor MN; Mead S; Bocchetta M; Boeve BF; Knopman DS; Graff-Radford NR; Forsberg LK; Rademakers R; Wszolek ZK; van Swieten JC; Jiskoot LC; Meeter LH; Dopper EG; Papma JM; Snowden JS; Saxon J; Jones M; Pickering-Brown S; Le Ber I; Camuzat A; Brice A; Caroppo P; Ghidoni R; Pievani M; Benussi L; Binetti G; Dickerson BC; Lucente D; Krivensky S; Graff C; Öijerstedt L; Fallström M; Thonberg H; Ghoshal N; Morris JC; Borroni B; Benussi A; Padovani A; Galimberti D; Scarpini E; Fumagalli GG; Mackenzie IR; Hsiung GYR; Sengdy P; Boxer AL; Rosen H; Taylor JB; Synofzik M; Wilke C; Sulzer P; Hodges JR; Halliday G; Kwok J; Sanchez-Valle R; Lladó A; Borrego-Ecija S; Santana I; Almeida MR; Tábuas-Pereira M; Moreno F; Barandiaran M; Indakoetxea B; Levin J; Danek A; Rowe JB; Cope TE; Otto M; Anderl-Straub S; de Mendonça A; Maruta C; Masellis M; Black SE; Couratier P; Lautrette G; Huey ED; Sorbi S; Nacmias B; Laforce R; Tremblay MPL; Vandenberghe R; Damme PV; Rogalski EJ; Weintraub S; Gerhard A; Onyike CU; Ducharme S; Papageorgiou SG; Ng ASL; Brodtmann A; Finger E; Guerreiro R, 2020, 'Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study', The Lancet Neurology, 19, pp. 145 - 156, http://dx.doi.org/10.1016/S1474-4422(19)30394-1

Matar E; Ehgoetz Martens KA; Halliday GM; Lewis SJG, 2020, 'Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology', Journal of Neurology, 267, pp. 380 - 389, http://dx.doi.org/10.1007/s00415-019-09583-8

Orme T; Hernandez D; Ross OA; Kun-Rodrigues C; Darwent L; Shepherd CE; Parkkinen L; Ansorge O; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Trojanowski JQ; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday G; Stone DJ; Dickson DW; Hardy J; Singleton A; Guerreiro R; Bras J, 2020, 'Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies', Acta Neuropathologica Communications, 8, http://dx.doi.org/10.1186/s40478-020-0879-z

Carter A; Richards LJ; Apthorp D; Azghadi MR; Badcock DR; Balleine B; Bekkers JM; Berk M; Bourne JA; Bradley AP; Breakspear M; Brichta A; Carter O; Castles A; Chakli K; Cohen-Woods S; Conn SJ; Cornish J; Cornish K; de Zubicaray G; Egan GF; Enticott PG; Fitzgibbon BM; Forlini C; Fornito A; Griffiths L; Gullifer J; Hall W; Halliday G; Hannan AJ; Harrer S; Harvey A; Hatherly C; Hickie IB; Kennett J; Kiernan M; Kilpatrick T; Kiral-Kornek I; Korgaonkar MS; Lawrence AJ; Leventer R; Levy N; Licinio J; Lovell N; Mackellar G; Malcolm L; Mason A; Mattingley JB; Medland SE; Michie PT; Nithianantharajah J; Parker J; Payne JM; Poole-Warren L; Sah P; Sarnyai Z; Schofield PR; Shimoni O; Shum DHK; Silk T; Slee M; Smith AE; Soulis T; Sriram S; Stuart GJ; Tapson J; Thompson MB; van Schaik A; Vincent NA; Vissel B; Waters A, 2020, 'Erratum: A Neuroethics Framework for the Australian Brain Initiative (Neuron (2019) 101(3) (365–369), (S0896627319300054), (10.1016/j.neuron.2019.01.004))', Neuron, 105, pp. 201, http://dx.doi.org/10.1016/j.neuron.2019.12.019

Szeto JYY; Walton CC; Rizos A; Martinez-Martin P; Halliday GM; Naismith SL; Chaudhuri KR; Lewis SJG, 2020, 'Dementia in long-term Parkinson's disease patients: a multicentre retrospective study.', NPJ Parkinsons Dis, 6, pp. 2, http://dx.doi.org/10.1038/s41531-019-0106-4

Forrest SL; Halliday GM; Sizemova A; van Roijen M; McGinley CV; Bright F; Kapur M; McGeachie AB; McCann H; Shepherd CE; Tan RH; Affleck AJ; Huang Y; Kril JJ, 2020, 'A practical approach to differentiate the frontotemporal tauopathy subtypes', Journal of Neuropathology and Experimental Neurology, 79, pp. 1122 - 1126, http://dx.doi.org/10.1093/jnen/nlaa100

Affleck AJ; Sachdev PS; Stevens J; Halliday GM, 2020, 'Antihypertensive medications ameliorate Alzheimer's disease pathology by slowing its propagation', Alzheimer's and Dementia: Translational Research and Clinical Interventions, 6, http://dx.doi.org/10.1002/trc2.12060

Ehgoetz Martens KA; Matar E; Hall JM; Phillips J; Szeto JYY; Gouelle A; Grunstein RR; Halliday GM; Lewis SJG, 2020, 'Invited Reply to: “Instrumental Analysis of Gait Abnormalities in Idiopathic Rapid Eye Movement Sleep Behavior Disorder”', Movement Disorders, 35, pp. 195 - 196, http://dx.doi.org/10.1002/mds.27939

Amadoru S; Doré V; McLean C; Hinton F; Shepherd C; Halliday G; Leyton C; Yates P; Hodges J; Masters C; Villemagne V; Rowe C, 2020, 'Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s Disease', , http://dx.doi.org/10.21203/rs.2.17082/v2

Bechara JA; Brooks WS; Kwok JB; Halliday GM; Schofield PR, 2020, 'Familial Alzheimer’s disease in Australia', Alzheimer's & Dementia, 16, http://dx.doi.org/10.1002/alz.040062

Roudeau S; Trist B; Carmona A; Davies K; M. Halliday G; Rufin Y; Claverol S; Van Malderen SJM; Falkenberg G; Double K; Ortega R, 2020, 'Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: A Methodological Workflow', , http://dx.doi.org/10.26434/chemrxiv.13415918.v1

Pires G; McElligott S; Drusinsky S; Halliday G; Potier MC; Wisniewski T; Drummond E, 2019, 'Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies', Acta Neuropathologica Communications, 7, http://dx.doi.org/10.1186/s40478-019-0848-6

Bonham LW; Steele NZR; Karch CM; Broce I; Geier EG; Wen NL; Momeni P; Hardy J; Miller ZA; Gorno-Tempini ML; Hess CP; Lewis P; Miller BL; Seeley WW; Manzoni C; Desikan RS; Baranzini SE; Ferrari R; Yokoyama JS; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Landqvist Waldö M; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Cruts M; Van Broeckhoven C; Cappa SF; Leber I; Hannequin D, 2019, 'Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia', Scientific Reports, 9, http://dx.doi.org/10.1038/s41598-019-46415-1

Forrest SL; Halliday GM; McCann H; McGeachie AB; McGinley CV; Hodges JR; Piguet O; Kwok JB; Spillantini MG; Kril JJ, 2019, 'Heritability in frontotemporal tauopathies', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 11, pp. 115 - 124, http://dx.doi.org/10.1016/j.dadm.2018.12.001

Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; Adarmes-Gómez AD; Aguilar M; Aitkulova A; Akhmetzhanov V; Alcalay RN; Alvarez I; Alvarez V; Barrero FJ; Bergareche Yarza JA; Bernal-Bernal I; Billingsley K; Blazquez M; Bonilla-Toribio M; Boungiorno MT; Brockmann K; Bubb V; Buiza-Rueda D; Cámara A; Carrillo F; Carrión-Claro M; Cerdan D; Chelban V; Clarimón J; Clarke C; Compta Y; Cookson MR; Craig DW; Danjou F; Diez-Fairen M; Dols-Icardo O; Duarte J; Duran R; Escamilla-Sevilla F; Escott-Price V; Ezquerra M; Feliz C; Fernández M; Fernández-Santiago R; Finkbeiner S; Foltynie T; Garcia C; García-Ruiz P; Gomez Heredia MJ; Gómez-Garre P; González MM; Gonzalez-Aramburu I; Guelfi S; Guerreiro R, 2019, 'Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies', The Lancet Neurology, 18, pp. 1091 - 1102, http://dx.doi.org/10.1016/S1474-4422(19)30320-5

Reynolds RH; Botía J; Nalls MA; Noyce AJ; Nicolas A; Cookson MR; Bandres-Ciga S; Gibbs JR; Hernandez DG; Singleton AB; Reed X; Leonard H; Blauwendraat C; Faghri F; Bras J; Guerreiro R; Tucci A; Kia DA; Houlden H; Plun-Favreau H; Mok KY; Wood NW; Lovering R; R’Bibo L; Rizig M; Chelban V; Trabzuni D; Tan M; Morris HR; Middlehurst B; Quinn J; Billingsley K; Holmans P; Kinghorn KJ; Lewis P; Escott-Price V; Williams N; Foltynie T; Brice A; Danjou F; Lesage S; Corvol JC; Martinez M; Giri A; Schulte C; Brockmann K; Simón-Sánchez J; Heutink P; Gasser T; Rizzu P; Sharma M; Shulman JM; Robak L; Lubbe S; Mencacci NE; Finkbeiner S; Lungu C; Scholz SW; Gan-Or Z; Rouleau GA; Krohan L; van Hilten JJ; Marinus J; Adarmes-Gómez AD; Bernal-Bernal I; Bonilla-Toribio M; Buiza-Rueda D; Carrillo F; Carrión-Claro M; Mir P; Gómez-Garre P; Jesús S; Labrador-Espinosa MA; Macias D; Vargas-González L; Méndez-del-Barrio C; Periñán-Tocino T; Tejera-Parrado C; Diez-Fairen M; Aguilar M; Alvarez I; Boungiorno MT; Carcel M; Pastor P; Tartari JP; Alvarez V; González MM; Blazquez M; Garcia C; Suarez-Sanmartin E; Barrero FJ; Rezola EM; Yarza JAB; Pagola AG; de Munain Arregui AL; Ruiz-Martínez J; Cerdan D; Duarte J; Clarimón J; Dols-Icardo O, 2019, 'Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability', npj Parkinson's Disease, 5, http://dx.doi.org/10.1038/s41531-019-0076-6

Ahmadi Rastegar D; Ho N; Halliday GM; Dzamko N, 2019, 'Parkinson’s progression prediction using machine learning and serum cytokines', npj Parkinson's Disease, 5, http://dx.doi.org/10.1038/s41531-019-0086-4

Strohäker T; Jung BC; Liou SH; Fernandez CO; Riedel D; Becker S; Halliday GM; Bennati M; Kim WS; Lee SJ; Zweckstetter M, 2019, 'Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts', Nature Communications, 10, http://dx.doi.org/10.1038/s41467-019-13564-w

McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Fat SCM; Wu SSL; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S, 2019, 'Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice', Journal of Neurology, Neurosurgery and Psychiatry, 91, pp. 162 - 171, http://dx.doi.org/10.1136/jnnp-2019-321790

Yang Y; Halliday GM; Kiernan MC; Tan RH, 2019, 'TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions', Neurology, 93, pp. e1748 - e1755, http://dx.doi.org/10.1212/WNL.0000000000008439

Forrest SL; Kril JJ; Halliday GM, 2019, 'Cellular and regional vulnerability in frontotemporal tauopathies', Acta Neuropathologica, 138, pp. 705 - 727, http://dx.doi.org/10.1007/s00401-019-02035-7

Virachit S; Mathews KJ; Cottam V; Werry E; Galli E; Rappou E; Lindholm P; Saarma M; Halliday GM; Shannon Weickert C; Double KL, 2019, 'Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson’s disease', Brain Pathology, 29, pp. 813 - 825, http://dx.doi.org/10.1111/bpa.12730

Hsiao JHT; Purushothuman S; Jensen PH; Halliday GM; Kim WS, 2019, 'Reductions in COQ2 Expression Relate to Reduced ATP Levels in Multiple System Atrophy Brain', Frontiers in Neuroscience, 13, http://dx.doi.org/10.3389/fnins.2019.01187

Matar E; Shine JM; Halliday GM; Lewis SJG, 2019, 'Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework', Brain, http://dx.doi.org/10.1093/brain/awz311

Leak RK; Frosch MP; Beach TG; Halliday GM, 2019, 'Alpha-synuclein: prion or prion-like?', Acta Neuropathologica, 138, pp. 509 - 514, http://dx.doi.org/10.1007/s00401-019-02057-1

Shehadeh J; Double KL; Murphy KE; Bobrovskaya L; Reyes S; Dunkley PR; Halliday GM; Dickson PW, 2019, 'Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease', Neurobiology of Disease, 130, http://dx.doi.org/10.1016/j.nbd.2019.104524

Gao J; Perera G; Bhadbhade M; Halliday GM; Dzamko N, 2019, 'Autophagy activation promotes clearance of α-synuclein inclusions in fibril-seeded human neural cells', Journal of Biological Chemistry, 294, pp. 14241 - 14256, http://dx.doi.org/10.1074/jbc.RA119.008733

Ke YD; Chan G; Stefanoska K; Au C; Bi M; Müller J; Przybyla M; Feiten A; Prikas E; Halliday GM; Piguet O; Kiernan MC; Kassiou M; Hodges JR; Loy CT; Mattick JS; Ittner A; Kril JJ; Sutherland GT; Ittner LM, 2019, 'CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation', Journal of Biological Chemistry, 294, pp. 14149 - 14162, http://dx.doi.org/10.1074/jbc.RA118.005263

Lee JS; Kanai K; Suzuki M; Kim WS; Yoo HS; Fu YH; Kim DK; Jung BC; Choi M; Oh KW; Li Y; Nakatani M; Nakazato T; Sekimoto S; Funayama M; Yoshino H; Kubo SI; Nishioka K; Sakai R; Ueyama M; Mochizuki H; Lee HJ; Sardi SP; Halliday GM; Nagai Y; Lee PH; Hattori N; Lee SJ, 2019, 'Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone', Brain, 142, pp. 2845 - 2859, http://dx.doi.org/10.1093/brain/awz205

Matar E; Phillips JR; Martens KAE; Halliday GM; Lewis SJG, 2019, 'Impaired Color Discrimination—A Specific Marker of Hallucinations in Lewy Body Disorders', Journal of Geriatric Psychiatry and Neurology, 32, pp. 257 - 264, http://dx.doi.org/10.1177/0891988719845501

Shepherd CE; McGeachie AB; Affleck AJ; Halliday GM, 2019, 'Letter to the editor', Journal of Neuropathology and Experimental Neurology, 78, pp. 975, http://dx.doi.org/10.1093/jnen/nlz069

Bright F; Werry EL; Dobson-Stone C; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kassiou M; Kril JJ, 2019, 'Neuroinflammation in frontotemporal dementia', Nature Reviews Neurology, 15, pp. 540 - 555, http://dx.doi.org/10.1038/s41582-019-0231-z

Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Fardo DW; Flanagan ME; Halliday G; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Dirk Keene C; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murray ME; Nag S; Seeley WW; Sperling RA; White CL; Schneider JA, 2019, 'Reply: LATE to the PART-y', Brain, 142, pp. 1 - 3, http://dx.doi.org/10.1093/brain/awz226

Ehgoetz Martens KA; Matar E; Hall JM; Phillips J; Szeto JYY; Gouelle A; Grunstein RR; Halliday GM; Lewis SJG, 2019, 'Subtle gait and balance impairments occur in idiopathic rapid eye movement sleep behavior disorder', Movement Disorders, 34, pp. 1374 - 1380, http://dx.doi.org/10.1002/mds.27780

Zhang Q; Vallerga CL; Walker RM; Lin T; Henders AK; Montgomery GW; He J; Fan D; Fowdar J; Kennedy M; Pitcher T; Pearson J; Halliday G; Kwok JB; Hickie I; Lewis S; Anderson T; Silburn PA; Mellick GD; Harris SE; Redmond P; Murray AD; Porteous DJ; Haley CS; Evans KL; McIntosh AM; Yang J; Gratten J; Marioni RE; Wray NR; Deary IJ; McRae AF; Visscher PM, 2019, 'Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing', Genome Medicine, 11, http://dx.doi.org/10.1186/s13073-019-0667-1

Heinzel S; Berg D; Gasser T; Chen H; Yao C; Postuma RB; Adler CH; Bloem B; Chan P; Deuschl G; Dubois B; Goetz CG; Halliday GM; Hardy J; Lang AE; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M, 2019, 'Update of the MDS research criteria for prodromal Parkinson's disease', MOVEMENT DISORDERS, 34, pp. 1464 - 1470, http://dx.doi.org/10.1002/mds.27802

Buckland ME; Sy J; Szentmariay I; Kullen A; Lee M; Harding A; Halliday G; Suter CM, 2019, 'Erratum: Correction to: Chronic traumatic encephalopathy in two former Australian National Rugby League players (Acta neuropathologica communications (2019) 7 1 (97))', Acta neuropathologica communications, 7, pp. 122, http://dx.doi.org/10.1186/s40478-019-0772-9

Katzeff JS; Phan K; Purushothuman S; Halliday GM; Kim WS, 2019, 'Cross-examining candidate genes implicated in multiple system atrophy', Acta neuropathologica communications, 7, pp. 117, http://dx.doi.org/10.1186/s40478-019-0769-4

Crook A; McEwen A; Fifita JA; Zhang K; Kwok JB; Halliday G; Blair IP; Rowe DB, 2019, 'The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20, pp. 310 - 316, http://dx.doi.org/10.1080/21678421.2019.1588904

Stankovic I; Quinn N; Vignatelli L; Antonini A; Berg D; Coon E; Cortelli P; Fanciulli A; Ferreira JJ; Freeman R; Halliday G; Höglinger GU; Iodice V; Kaufmann H; Klockgether T; Kostic V; Krismer F; Lang A; Levin J; Low P; Mathias C; Meissner WG; Kaufmann LN; Palma JA; Panicker JN; Pellecchia MT; Sakakibara R; Schmahmann J; Scholz SW; Singer W; Stamelou M; Tolosa E; Tsuji S; Seppi K; Poewe W; Wenning GK, 2019, 'A critique of the second consensus criteria for multiple system atrophy', Movement Disorders, 34, pp. 975 - 984, http://dx.doi.org/10.1002/mds.27701

Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Chui HC; Fardo DW; Flanagan ME; Halliday G; Hokkanen SRK; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Keene CD; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murayama S; Murray ME; Nag S; Rissman RA; Seeley WW; Sperling RA; White CL; Yu L; Schneider JA, 2019, 'Erratum: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (Brain (2019) 142, (1503–1527) DOI: 10.1093/brain/awz099)', Brain, 142, http://dx.doi.org/10.1093/brain/awz163

Back to profile page